Johnson & Johnson to Participate in the 2023 Wells Fargo Securities Healthcare Conference

Rhea-AI Summary

Johnson & Johnson (JNJ) to participate in 2023 Wells Fargo Securities Healthcare Conference, featuring EVP Ashley McEvoy. Investors can access the conference call on the company's website. Webcast and podcast replay available after 48 hours.

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)-- Johnson & Johnson (NYSE: JNJ) will participate in the 2023 Wells Fargo Securities Healthcare Conference at the Encore Boston Harbor in Everett, MA on Thursday, September 7^th. Ashley McEvoy, EVP, Worldwide Chairman, MedTech along with executives from Abiomed will represent the Company in a session scheduled at 10:15 a.m. (Eastern Time).

This conference call will be available to investors and other interested parties by visiting the Johnson & Johnson website at www.investor.jnj.com.

A webcast and podcast replay will be available approximately 48 hours after the live webcast.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230807587886/en/

Investor Contact:

RA-JJCUS-InvestorRel@ITS.JNJ.com

Media Contact:

media-relations@its.jnj.com

Source: Johnson & Johnson

FAQ

What event is Johnson & Johnson participating in on September 7th, 2023?

Johnson & Johnson will participate in the 2023 Wells Fargo Securities Healthcare Conference at the Encore Boston Harbor in Everett, MA.

Who will represent Johnson & Johnson at the conference?

Ashley McEvoy, EVP, Worldwide Chairman, MedTech, along with executives from Abiomed.

How can investors access the conference call?

Investors can access the conference call by visiting the Johnson & Johnson website at www.investor.jnj.com.

When will the webcast and podcast replay be available?

The webcast and podcast replay will be available approximately 48 hours after the live webcast.